These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16267727)

  • 41. Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration.
    Herbrecht R; Nivoix Y
    Clin Infect Dis; 2005 Jun; 40(11):1635-7. PubMed ID: 15889361
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
    Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S
    Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
    Thompson GR; Wiederhold NP; Sutton DA; Fothergill A; Patterson TF
    J Antimicrob Chemother; 2009 Jul; 64(1):79-83. PubMed ID: 19406849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
    Muñoz P; Singh N; Bouza E
    Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: Part II.
    Moyad MA
    Urol Nurs; 2008 Feb; 28(1):73-5. PubMed ID: 18335702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exogenous fungal endophthalmitis: microbiology and clinical outcomes.
    Wykoff CC; Flynn HW; Miller D; Scott IU; Alfonso EC
    Ophthalmology; 2008 Sep; 115(9):1501-7, 1507.e1-2. PubMed ID: 18486220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism.
    Cassone M; Serra P; Mondello F; Girolamo A; Scafetti S; Pistella E; Venditti M
    J Clin Microbiol; 2003 Nov; 41(11):5340-3. PubMed ID: 14605200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis.
    Kaya Z; Gursel T; Kocak U; Aral YZ; Kalkanci A; Albayrak M
    Pediatr Blood Cancer; 2009 Apr; 52(4):470-5. PubMed ID: 19058205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fungal infections in children with cancer: a prospective, multicenter surveillance study.
    Castagnola E; Cesaro S; Giacchino M; Livadiotti S; Tucci F; Zanazzo G; Caselli D; Caviglia I; Parodi S; Rondelli R; Cornelli PE; Mura R; Santoro N; Russo G; De Santis R; Buffardi S; Viscoli C; Haupt R; Rossi MR
    Pediatr Infect Dis J; 2006 Jul; 25(7):634-9. PubMed ID: 16804435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of yeasts in diabetic foot ulcer infection].
    Missoni EM; Kalenić S; Vukelić M; De Syo D; Belicza M; Kern J; Babić VV
    Acta Med Croatica; 2006; 60(1):43-50. PubMed ID: 16802571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii.
    Barc MC; Charrin-Sarnel C; Rochet V; Bourlioux F; Sandré C; Boureau H; Doré J; Collignon A
    Anaerobe; 2008 Oct; 14(4):229-33. PubMed ID: 18511310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fungal respiratory disease.
    Yao Z; Liao W
    Curr Opin Pulm Med; 2006 May; 12(3):222-7. PubMed ID: 16582678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Morphological and biochemical features of fungi isolated from patients with renal failure].
    Drozdowska A
    Wiad Parazytol; 2007; 53(2):145-8. PubMed ID: 17912812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fungal peritonitis in peritoneal dialysis patients: Is previous antibiotic therapy an essential condition?
    Rosa NG; Silva S; Lopes JA; Branco P; de Almeida E; Ribeiro C; Abreu F; Barbas J; Prata MM
    Mycoses; 2007 Jan; 50(1):79-81. PubMed ID: 17302754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
    Cornely OA; Böhme A; Reichert D; Reuter S; Maschmeyer G; Maertens J; Buchheidt D; Paluszewska M; Arenz D; Bethe U; Effelsberg J; Lövenich H; Sieniawski M; Haas A; Einsele H; Eimermacher H; Martino R; Silling G; Hahn M; Wacker S; Ullmann AJ; Karthaus M;
    J Antimicrob Chemother; 2008 Apr; 61(4):939-46. PubMed ID: 18272515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of hepatic iron overload with invasive fungal infection in liver transplant recipients.
    Alexander J; Limaye AP; Ko CW; Bronner MP; Kowdley KV
    Liver Transpl; 2006 Dec; 12(12):1799-804. PubMed ID: 16741903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Unrecognized vaginal mycoses: infection with Brewer's and Baker's yeasts].
    Nicoli RM; Russo A; Sempe M
    Gynecol Prat; 1972; 23(4):177-9. PubMed ID: 4575890
    [No Abstract]   [Full Text] [Related]  

  • 60. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.